Ocugen News

Ocugen Analyst Ratings

BenzingaMay 15 06:47 ET

Buy Rating Affirmed for Ocugen on Strong Financials and Advancing Clinical Pipeline

TipRanksMay 15 06:40 ET

Ocugen Analyst Ratings

BenzingaApr 22 07:46 ET

Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Ocugen (OCGN) and Moderna (MRNA)

TipRanksApr 9 08:16 ET

Ocugen Analyst Ratings

BenzingaApr 3 06:47 ET

Buy Rating Affirmed for Ocugen on Strong Clinical Progress and Financial Stability

TipRanksApr 3 06:30 ET

Ocugen Analyst Ratings

BenzingaFeb 22 06:45 ET

Buy Rating Affirmed for Ocugen on Strong Clinical Progress and Positive Financial Outlook

TipRanksFeb 22 06:20 ET

Ocugen Analyst Ratings

BenzingaJan 24 06:17 ET

Analyst Gives 'Buy' Rating to Ocugen Backed by Strong Financial Position and Promising Drug Pipeline

TipRanksNov 10, 2023 12:55 ET

H.C. Wainwright Sticks to Their Buy Rating for Ocugen (OCGN)

TipRanksSep 14, 2023 10:05 ET

Cantor Fitzgerald Maintains Overweight on Ocugen, Lowers Price Target to $2

BenzingaAug 31, 2023 10:19 ET

Ocugen Analyst Ratings

BenzingaAug 31, 2023 10:18 ET

Ocugen (OCGN) Gets a Buy From Noble Financial

TipRanksAug 23, 2023 08:05 ET

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), LAVA Therapeutics (LVTX) and Ocugen (OCGN)

TipRanksAug 23, 2023 06:20 ET

HC Wainwright & Co. Reiterates Buy on Ocugen, Maintains $5 Price Target

BenzingaAug 23, 2023 06:15 ET

Ocugen Analyst Ratings

BenzingaAug 23, 2023 06:15 ET

Ocugen (OCGN) Gets a Buy From Noble Financial

TipRanksMay 8, 2023 08:11 ET

Chardan Research Raises Ocugen's Price Target to $4 From $3.50, Buy Rating Kept

MT NewswiresMay 8, 2023 07:11 ET

Chardan Capital Maintains Buy on Ocugen, Raises Price Target to $4

BenzingaMay 8, 2023 04:33 ET